Lost his taste; Lost his smell; has a cough; got the sniffles; felt better but had a headache; his appetite was down.; he got a sore arm/stayed in bed until Sunday; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost his taste), ANOSMIA (Lost his smell), COUGH (has a cough), RHINORRHOEA (got the sniffles) and DECREASED APPETITE (his appetite was down.) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006D21A, 028L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, the patient experienced DECREASED APPETITE (his appetite was down.) and PAIN IN EXTREMITY (he got a sore arm/stayed in bed until Sunday). On 21-Nov-2021, the patient experienced HEADACHE (felt better but had a headache). On 22-Nov-2021, the patient experienced RHINORRHOEA (got the sniffles). On 23-Nov-2021, the patient experienced AGEUSIA (Lost his taste), ANOSMIA (Lost his smell) and COUGH (has a cough). At the time of the report, AGEUSIA (Lost his taste), ANOSMIA (Lost his smell), COUGH (has a cough), RHINORRHOEA (got the sniffles), DECREASED APPETITE (his appetite was down.), PAIN IN EXTREMITY (he got a sore arm/stayed in bed until Sunday) and HEADACHE (felt better but had a headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported. No treatment reported.  Company Comment: This spontaneous case concerns a 64 year old male with no reported medical history who experienced, Non-serious , unexpected , AESI event of Anosmia and Ageusia which occurred 5 days after the vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) , Other non-serious , unexpected events include pain in extremity, decreased appetite, rhinorrhea , cough and expected event of headache was also experienced by the patient after receiving the 3rd dose of the vaccine. The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be administered and also the outcome of th events were reported as unkown, The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report; Sender's Comments: This spontaneous case concerns a 64 year old male with no reported medical history who experienced, Non-serious , unexpected , AESI event of Anosmia and Ageusia which occurred 5 days after the vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) , Other non-serious , unexpected events include pain in extremity, decreased appetite, rhinorrhea , cough and expected event of headache was also experienced by the patient after receiving the 3rd dose of the vaccine. The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be administered and also the outcome of th events were reported as unkown, The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.